<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Sci Rep</journal-id>
    <journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id>
    <journal-title-group>
      <journal-title>Scientific Reports</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2045-2322</issn>
    <publisher>
      <publisher-name>Nature Publishing Group UK</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10170056</article-id>
    <article-id pub-id-type="pmid">37165197</article-id>
    <article-id pub-id-type="publisher-id">34729</article-id>
    <article-id pub-id-type="doi">10.1038/s41598-023-34729-0</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>PeruNPDB: the Peruvian Natural Products Database for in silico drug screening</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Barazorda-Ccahuana</surname>
          <given-names>Haruna L.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ranilla</surname>
          <given-names>Lena Gálvez</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Candia-Puma</surname>
          <given-names>Mayron Antonio</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cárcamo-Rodriguez</surname>
          <given-names>Eymi Gladys</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Centeno-Lopez</surname>
          <given-names>Angela Emperatriz</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Davila-Del-Carpio</surname>
          <given-names>Gonzalo</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Medina-Franco</surname>
          <given-names>José L.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Chávez-Fumagalli</surname>
          <given-names>Miguel Angel</given-names>
        </name>
        <address>
          <email>mchavezf@ucsm.edu.pe</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.441990.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2226 7599</institution-id><institution>Computational Biology and Chemistry Research Group, Vicerrectorado de Investigación, </institution><institution>Universidad Católica de Santa María, </institution></institution-wrap>04000 Arequipa, Peru </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.441990.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2226 7599</institution-id><institution>Laboratory of Research in Food Science, </institution><institution>Universidad Catolica de Santa Maria, </institution></institution-wrap>04000 Arequipa, Peru </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.441990.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2226 7599</institution-id><institution>Escuela Profesional de Ingeniería de Industria Alimentaria, Facultad de Ciencias e Ingenierías Biológicas y Químicas, </institution><institution>Universidad Catolica de Santa Maria, </institution></institution-wrap>04000 Arequipa, Peru </aff>
      <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.441990.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2226 7599</institution-id><institution>Facultad de Ciencias Farmacéuticas, Bioquímicas y Biotecnológicas, </institution><institution>Universidad Católica de Santa María, </institution></institution-wrap>04000 Arequipa, Peru </aff>
      <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.9486.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2159 0001</institution-id><institution>DIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, </institution><institution>Universidad Nacional Autónoma de México, </institution></institution-wrap>04510 Mexico City, Mexico </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>10</day>
      <month>5</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>10</day>
      <month>5</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>13</volume>
    <elocation-id>7577</elocation-id>
    <history>
      <date date-type="received">
        <day>18</day>
        <month>1</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>6</day>
        <month>5</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <p id="Par1">Since the number of drugs based on natural products (NPs) represents a large source of novel pharmacological entities, NPs have acquired significance in drug discovery. Peru is considered a megadiverse country with many endemic species of plants, terrestrial, and marine animals, and microorganisms. NPs databases have a major impact on drug discovery development. For this reason, several countries such as Mexico, Brazil, India, and China have initiatives to assemble and maintain NPs databases that are representative of their diversity and ethnopharmacological usage. We describe the assembly, curation, and chemoinformatic evaluation of the content and coverage in chemical space, as well as the physicochemical attributes and chemical diversity of the initial version of the Peruvian Natural Products Database (PeruNPDB), which contains 280 natural products. Access to PeruNPDB is available for free (<ext-link ext-link-type="uri" xlink:href="https://perunpdb.com.pe/">https://perunpdb.com.pe/</ext-link>). The PeruNPDB’s collection is intended to be used in a variety of tasks, such as virtual screening campaigns against various disease targets or biological endpoints. This emphasizes the significance of biodiversity protection both directly and indirectly on human health.</p>
    </abstract>
    <kwd-group kwd-group-type="npg-subject">
      <title>Subject terms</title>
      <kwd>Chemical biology</kwd>
      <kwd>Computational biology and bioinformatics</kwd>
      <kwd>Drug discovery</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Universidad Catolica de Santa Maria, Peru</institution>
        </funding-source>
        <award-id>7309-CU-2020</award-id>
        <award-id>27499-R-2020</award-id>
        <principal-award-recipient>
          <name>
            <surname>Barazorda-Ccahuana</surname>
            <given-names>Haruna L.</given-names>
          </name>
          <name>
            <surname>Chávez-Fumagalli</surname>
            <given-names>Miguel Angel</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Universidad Catolica de Santa Maria</institution>
        </funding-source>
        <award-id>28048-R-2021</award-id>
        <principal-award-recipient>
          <name>
            <surname>Barazorda-Ccahuana</surname>
            <given-names>Haruna L.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© Springer Nature Limited 2023</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Introduction</title>
    <p id="Par2">Biodiversity is the variety of all life forms, including the morphological diversity of individuals and populations within a species, the taxonomic diversity of species within a community or ecosystem, the functional diversity of groups of species within an ecosystem, and the diversity of ecosystems themselves<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. While the total number of species in every taxonomic group has been predicted for all kingdoms of life on earth at approximately 8.7 million<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>, it is remarkable that the distribution of that vast number of species is highly concentrated in specific areas. These regions are particularly important for biodiversity conservation and are called biodiversity hotspots<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>, although: Bolivia, Brazil, China, Colombia, Costa Rica, the Democratic Republic of Congo, Ecuador, India, Indonesia, Kenya, Madagascar, Malaysia, Mexico, Peru, Philippines, South Africa, and Venezuela are considered megadiverse countries<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Peru occupies the seventh place in this group, as it possesses 28 of the 32 existing climates in the world and 84 of the 103 life zones known on earth. This is evidenced by considering that the country has 25,000 plant species or 10% of the entire number of species worldwide, whereas 30% are endemic, and endemic animal species such as 115 birds, 109 mammals, and 185 amphibians species, which represent 6, 27.5 and 48.5% of the total number worldwide, respectively<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup>.</p>
    <p id="Par3">Biodiversity conservation is important since plants, animals, and other life forms such as bacteria, archaea, protozoa, and fungi, are used directly or indirectly to produce pharmaceuticals, and for their scientific value, among other resources<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. The number of drugs derived from natural products (NP) that were introduced to the market over forty years represented a significant source of new pharmacological entities<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Whilst the Peruvian population uses approximately 5000 Peruvian plants for 49 purposes or applications, where about 1400 species are described as medicinal<sup><xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR13">13</xref></sup>. The contribution from traditional Peruvian medicine can be embodied by Quinine, a component of the bark of the cinchona tree (<italic>Cinchona officinalis</italic>), employed in the treatment of Malaria<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Additionally, two other valuable contributions to modern pharmacopeias such as the coca plant (<italic>Erythroxylum coca</italic>), from which cocaine was first isolated and later led to local anesthetics<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, and the balsam of Peru (<italic>Myroxylon balsamum</italic>), which was used wide-reaching for the treatment of wounds<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, can be mentioned. However, the potential of Peruvian NPs remains underexploited since most of these useful native species can be domesticated or semi-domesticated<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Also, the amount and nature of experimental evidence published on active NPs are still limited<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, and most of the current studies reported crude medicinal activities, while potentially active NPs have been isolated only from a few numbers of plants<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>.</p>
    <p id="Par4">Computer-aided drug design (CADD), one of the key approaches to modern pre-clinical drug discovery, can be defined as computational methods that are applied to discover, develop, and analyze drugs and active molecules<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. Among the key approaches that comprise CADD, virtual screening is one of the major contributors to CADD since it stands as a contemporary approach to the experimental in vitro high-throughput screening (HTS) for hit identification and optimization<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. Integrating CADD approaches to curated databases, which are described as a well-organized collection of data in any field, the drug development process may be sped up and cost reduced<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. Considering this, large databases containing NPs from various data sources have been released, such as the COlleCtion of Open Natural prodUcTs (COCONUT), which contains 406,076 unique “flat” NPs, and a total of 730,441 NPs where stereochemistry has been preserved<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>; and the LOTUS initiative, which has 750,000 referenced structure-organism pairs<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. Also, several NPs compound databases from particular geographical locations have been assembled, such as the Traditional Chinese Medicine (TCM) Database@Taiwan database containing approximately 58,000 molecules<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>; the Indian Medicinal Plants, Phytochemistry and Therapeutics 2.0 (IMPPAT 2.0) which contains more than 10,000 phytochemicals<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>; and the AfroDB which is composed of around 1000 NPs<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Likewise, some countries in Latin America have published their own public NPs databases such as NuBBEDB which contains more than 2000 NPs<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>, and SistematX which contains more than 2500 NPs<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>, both from Brazil, and BIOFACQUIM from Mexico, which contains a total of 531 molecules<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. Furthermore, NPs databases had been used as a repository to identify several promising candidates to be considered for further development for the treatment of diseases<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>, such as Chagas disease<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>, Tuberculosis<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, Leishmaniasis<sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>, Schistosomiasis<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>, and COVID-19<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. The present work introduces the first version of the Peruvian Natural Products Database (PeruNPDB), describing its assembly, curation, and chemoinformatic characterization of molecular diversity and coverage in chemical space. The database is freely available at the web-interface PeruNPDB Explorer (<ext-link ext-link-type="uri" xlink:href="https://perunpdb.com.pe/">https://perunpdb.com.pe/</ext-link>). We anticipate that the PeruNPDB will make it possible to conduct additional virtual screening tests to create innovative pharmacological entities and other biotechnological approaches and serve as a resource for information on conservation guidelines.</p>
  </sec>
  <sec id="Sec2">
    <title>Methods</title>
    <sec id="Sec3">
      <title>Search strategy, study selection, and data extraction</title>
      <p id="Par5">A systematic review search strategy to examine the literature for studies describing NP from Peruvian sources was adapted from<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. Whereas PubMed, the main database for the health sciences, maintained by the National Center for Biotechnology Information (NCBI) at the National Library of Medicine (NLM), is a database that contains about 32 million citations, belonging to more than 5300 journals currently indexed in MEDLINE<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>; it provides uniform indexing of biomedical literature, the Medical Subject Headings (MeSH terms), which form a controlled vocabulary or specific set of terms that describe the topic of a paper consistently and uniformly<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. Firstly, to find terms associated in the literature with Peruvian NPs, the MeSH terms “<italic>Peru</italic>” AND the “<italic>Natural Products</italic>” were employed in a search carried out at the PubMed database (<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/">https://pubmed.ncbi.nlm.nih.gov/</ext-link>), (last searched on 10 June 2022), though the results were plotted into a network map of the co-occurrence of MeSH terms in the VOSviewer software (version 1.6.17)<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>, which employs a modularity-based method algorithm to measure the strength of clusters<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. The resultant cluster content was analyzed to select relevant studies associated with Peruvian NPs. Three phases went into selecting the studies. First, papers written in languages other than English, copies of articles, reviews, and meta-analyses were disregarded. The highly relevant full studies were then retrieved and separated from the papers with a title or abstract that did not provide enough information to be included. Next, the titles and abstracts of the publications chosen through the search approach were visually evaluated. The data supplied from each investigation contained the NP’s characterization as well as details on the genus and species of the sources from which the NP were isolated. Additionally, the information from the bibliographic reference was extracted, even if all research that discussed chemicals derived from Peruvian natural sources was already considered.</p>
    </sec>
    <sec id="Sec4">
      <title>PeruNPDB assemble and molecular properties calculation</title>
      <p id="Par6">The simplified molecular-input line-entry system (SMILES)<sup><xref ref-type="bibr" rid="CR44">44</xref></sup> of compounds previously described in the NPs selected in the previous step were searched and retrieved from PubChem<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>, DrugBank<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>, or ChEMBL<sup><xref ref-type="bibr" rid="CR47">47</xref></sup> servers, while for unavailable NPs the ChemDraw tool<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> was employed to generate the SMILE notation. Moreover, the Osiris DataWarrior v05.02.01 software<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> was employed to generate the dataset’s structure data files (SDFs). This followed the uploading to the Konstanz information miner (KNIME) Analytics Platform<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>, where the “Molecular Type Cast”, and the “RDKit Structure Normalizer” KNIME nodes were employed to curate the chemical structures on the dataset. Moreover, for every compound in the dataset, the classification system for describing small molecule structures is described based on NP Classifier<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>, which employs a biosynthetic ontology that is specific to natural products; or ClassyFire<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> which is a general classification system for small molecules that are based on the ChemOnt ontology, was employed. The KNIME’s “RKDit Descriptor Calculator” node was employed to calculate six physicochemical properties of therapeutic interest, namely: molecular weight (MW), octanol/water partition coefficient (clogP), topological surface area (TPSA), aqueous solubility (clogS), number of H-bond donor atoms (HBD) and number of H-bond acceptor atoms (HBA) of the PeruNPDB, while the statistical analysis was done within the GraphPad Prism software version 9.4.0 for Windows, GraphPad Software, San Diego, California USA, <ext-link ext-link-type="uri" xlink:href="http://www.graphpad.com">http://www.graphpad.com</ext-link>, by calculating the mean, median, standard deviation, and the coefficient of variation of the calculated properties. Box-and-whisker plots showing, the maximum and minimum values were generated for visualization, and the One-way ANOVA followed by Dunnett correction for multiple comparisons test was employed to evaluate the differences between the datasets. The results were considered statistically significant when p&lt;0.05.</p>
    </sec>
    <sec id="Sec5">
      <title>Visual representation of chemical space</title>
      <p id="Par7">To generate a visual representation of the chemical space of the PeruNPDB, two visualization methods, for the auto-scaled six properties of pharmaceutical interest, namely: MW, ClogP, TPSA, clogS, HBD, and HBA, were employed: principal component analysis (PCA), which reduces data dimensions by geometrically projecting them onto lower dimensions called principal components (PCs)<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> calculated by the “PCA” KNIME node. The second technique was the t-distributed stochastic neighbor embedding (t-SNE), which is a nonlinear dimension reduction in which Gaussian probability distributions over high-dimensional space are constructed and used to optimize a student t-distribution in low-dimensional space<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>, calculated by the t-SNE (L. Jonsson) KNIME node. Three and two-dimensional scatter-plot representations were generated for PCA and t-SNE, respectively with the Plotly KNIME node. Additionally, the Tanimoto similarity score was calculated for clustering the compounds, while the atom-pair-based fingerprints of the NPs were obtained using the “ChemmineR” package<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> in the R programming environment (version 4.0.3)<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>, a heatmap was generated for visualization. The same procedure was employed in the reference datasets: AfroDB<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, BIOFAQUIM<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>, and NUBBEDB<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> retrieved from the ZINC20 database<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>.</p>
    </sec>
    <sec id="Sec6">
      <title>Global diversity: consensus diversity analysis</title>
      <p id="Par8">Since chemical diversity strongly depends on the structure representation, it is reasonable to consider multiple representations for a complete global assessment. The consensus diversity (CD) plots have been proposed as simple two-dimensional graphs that enable the comparison of the diversity of compound data sets using four sets of structural representations: the molecular fingerprints, scaffolds, molecular properties, and the number of NPs<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. The multiple-variable plot was generated by GraphPad Prism software version 9.4.0, whereas the y-axis represents the area under the cyclic system recovery curve<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>, the x-axis, represents the median of the fingerprint-based diversity computed with Molecular Access System (MACCS) keys (166-bits) and the Tanimoto coefficient<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>, the bubble color represents the molecular properties of pharmaceutical interest, and the bubble size represents the number of NPs for each database.</p>
    </sec>
    <sec id="Sec7">
      <title>Drug-likeness</title>
      <p id="Par9">The Osiris DataWarrior v05.02.01 software<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> was employed to calculate the drug-likeness score of the compounds from the PeruNPDB; the calculation is based on a library of  5300 substructure fragments and their associated drug-likeness scores. This library was prepared by fragmenting 3300 commercial drugs as well as 15,000 commercial non-drug-like Fluka NPs<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>. Frequency distribution of the obtained scores was performed at GraphPad Prism software version 9.4.0 for Windows, GraphPad Software, San Diego, California USA (<ext-link ext-link-type="uri" xlink:href="http://www.graphpad.com">http://www.graphpad.com</ext-link>), and plotted into stacked bar plots. Furthermore, the Lipinski Rule-of-5 (Ro5) is a set of four rules (logP, MW, and H-bond donor and acceptor cut-offs) for drug-likeness and oral bioavailability derived from a subset of 2245 drugs<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. For this Lipinski’s Ro5 KNIME node was employed to assess the number of violations to the rule for each compound on the PeruNPDB and plotted into pie charts. The US Food and Drug Administration (FDA)-approved drugs dataset<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>, was employed as a reference, whereas the same procedures were applied to their compounds. Also, the chemical space representation was analyzed, and the procedures were the same as described earlier.</p>
    </sec>
  </sec>
  <sec id="Sec8">
    <title>Results</title>
    <sec id="Sec9">
      <title>PeruNPDB assemble</title>
      <p id="Par10">In the present study, the assembly of the PeruNPDB, followed by its chemoinformatic characterization on molecular diversity and coverage of the chemical space was performed; to select the studies from which the NPs will further retrieve, a search with the MeSH Terms “<italic>Peru</italic>” AND “<italic>Natural Products</italic>” was performed in the Pubmed database, followed by the construction of a network map of the co-occurrence of MeSH terms. The workflow proposed in Fig. <xref rid="Fig1" ref-type="fig">1</xref> was considered. The search resulted in 399 published papers between 1950-2021, whereas establishing the value of five as the minimum number of occurrences of keywords, a map with 194 keywords that reaches the threshold was constructed (Fig. <xref rid="Fig2" ref-type="fig">2</xref>A). In the analysis of the map, it is shown that six main clusters were formed, while terms such as “<italic>Plant Extracts</italic>”, “<italic>Plants, medicinal</italic>”, “<italic>Phytotherapy</italic>”, “<italic>Ethnopharmacology</italic>”, “<italic>Ethnobotany</italic>”, “<italic>Plants stems</italic>”, “<italic>Plants bark</italic>”, and “<italic>Seeds</italic>”, which are associated with NPs were observed in the first cluster (red color). Also, terms such as “<italic>Peru</italic>”, “<italic>Humans</italic>”, “<italic>Animals</italic>”, and “<italic>Male</italic>”, were recurrent terms. Although using the eligibility criterion established, 47 articles were selected which showed a 2000-2021-year range, and terms such as “<italic>Flavonoids</italic>”, “<italic>Sesquiterpenes</italic>”, and “<italic>Anthocyanins</italic>”, were recurrent terms (Fig. <xref rid="Fig2" ref-type="fig">2</xref>B). Also, bibliographic data extracted from the selected articles analyzed: the “<italic>Journal of Agricultural and Food Chemistry</italic>”, the “<italic>Journal of Ethnopharmacology</italic>”, “<italic>Phytochemistry</italic>”, and “<italic>Planta Medica</italic>” where the main peer-reviewed journals were the studies describing compounds extracted from Peruvian NPs were published (Fig. <xref rid="Fig2" ref-type="fig">2</xref>C). Furthermore, while retrieving the SMILES of the compounds from PubChem, DrugBank, and ChEMBL, it was observed that 242 structures were found in the repositories and that 38 needed to be generated in the ChemDraw tool. Ninety-five and five percent of the compounds were retrieved from plant or animal sources, respectively (Fig. <xref rid="Fig3" ref-type="fig">3</xref>A). The genus from which most of the compounds were extracted were Uncaria and Lepidium, with 11 and 10 percent, respectively (Fig. <xref rid="Fig3" ref-type="fig">3</xref>B). When analyzing the structure of the compounds with a classification system for small molecule structures, it is shown that 76 classes of NPs were found among the 280 NPs of the PeruNPDB, whereas anthocyanidins (N=25), aporphine alkaloids (N=11), cinnamic acids and derivatives (N=17), germacrane sesquiterpenoids (N=13), stigmastane steroids (N=10), and unsaturated fatty acids (N=22) were the most predicted classes of NPs (Fig. <xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig1"><label>Figure 1</label><caption><p>General workflow to generate and curate the first version of the Peruvian natural product database. The graph was edited in SmartDraw 2023 Software, LLC (Accessed April 14, 2023).</p></caption><graphic xlink:href="41598_2023_34729_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Figure 2</label><caption><p>Bibliographic search for studies describing the characterization of Peruvian natural products. (<bold>A</bold>) Network map of the co-occurrence of MeSH terms. (<bold>B</bold>) Network map of articles selected from 2000 to 2021-year. (<bold>C</bold>) Bibliographic data extracted from selected articles that describe compounds extracted from Peruvian NPs.</p></caption><graphic xlink:href="41598_2023_34729_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Figure 3</label><caption><p>Dot plots showing the kingdom and genus of the species studied. (<bold>A</bold>) Compounds of Peruvian NPs found in PubChem, DrugBank, and ChEMBL databases. (<bold>B</bold>) Dot plot of the genus of the Peruvian NPs compounds obtained from the databases.</p></caption><graphic xlink:href="41598_2023_34729_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Figure 4</label><caption><p>Dot plots showing the natural products classification.</p></caption><graphic xlink:href="41598_2023_34729_Fig4_HTML" id="MO4"/></fig></p>
    </sec>
    <sec id="Sec10">
      <title>Molecular properties</title>
      <p id="Par11">Six physicochemical properties were calculated for all compounds in PeruNPDB and plotted into box plots, which include the distribution of the same properties of the three reference datasets, retrieved from the ZINC20 database (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). To compare the results of the datasets, the coefficient of variation (CV) was calculated, which represents the ratio of the standard deviation to the mean and is considered a useful tool to statistically compare the degree of variation from one dataset to another<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. Besides the results of the HBA, in which NuBBEDB obtain the highest CV (123.2%), the PeruNPDB showed the highest CV in MW, clogP, TPSA, clogS, and HBD with 46.58%, 84.49%, 112.8%, 50.08%, and 83.84%, respectively. Still, the results from TPSA, clogP, clogS, and HBD showed high statistical differences compared to AfroDB, BIOFAQUIM, and NuBBEDB, while showed no statistical difference in HBA results compared to the AfroNP database (Fig. <xref rid="Fig5" ref-type="fig">5</xref>).<fig id="Fig5"><label>Figure 5</label><caption><p>Box plots for the physicochemical properties of PeruNPDB and reference datasets.</p></caption><graphic xlink:href="41598_2023_34729_Fig5_HTML" id="MO5"/></fig></p>
    </sec>
    <sec id="Sec11">
      <title>Visualization of the chemical space</title>
      <p id="Par12">The chemical space visualization of PeruNPDB was conducted using PCA and t-SNE. Though the visual analysis of 3D-PCA shows that molecules in PeruNPDB share the chemical space roughly with NuBBEDB. Whereas in some regions the molecules of PeruNPDB are predominant (Fig. <xref rid="Fig6" ref-type="fig">6</xref>A). While the explained variance percentage of PC1, PC2, and PC3 was 50.24, 39.94, and 6.72, respectively. PeruNPDB, BIOFAQUIM, and NuBBEDB chemicals overlap in most of the chemical space represented, according to the 2D-t-SNE visual analysis (Fig. <xref rid="Fig6" ref-type="fig">6</xref>B).</p>
    </sec>
    <sec id="Sec12">
      <title>Diversity analysis</title>
      <p id="Par13">The heatmap generated using the Tanimoto score matrix and the atom-pair-based fingerprints show that there is a similarity between the structures of the compounds of the PeruNPDB, AfroDB, BIOFAQUIM, and NuBBEDB (Fig. <xref rid="Fig6" ref-type="fig">6</xref>C). Also, a consensus diversity plot was used to evaluate the diversity of the PeruNPDB dataset, based on molecular fingerprints, scaffolds, and physicochemical properties. The Euclidean distance of the scaled properties was used to compute the property-based diversity of the PeruNPDB, AfroDB, BIOFAQUIM, and NuBBEDB databases. Data points on a continuous color scale are used to represent the values on the color CD plot. Darker colors signify less diversity, but brighter colors signify more diversity. Finally, different point sizes are used to illustrate how large or tiny the databases are, with smaller data points indicating databases with fewer molecules. The results showed that the diversity of compounds found in the PeruNPDB was the largest since it was found in the area where the highest diversity in scaffold and fingerprints should are found (Fig. <xref rid="Fig7" ref-type="fig">7</xref>), which is consistent with the results shown in the box plots (Fig. <xref rid="Fig6" ref-type="fig">6</xref>).<fig id="Fig6"><label>Figure 6</label><caption><p>Visual representation of the chemical space of the PeruNPDB and reference datasets. (<bold>A</bold>) PeruNPDB 3D-PCA chemical space. (<bold>B</bold>) 2D-t-SNE visual analysis of the compounds PeruNPDB, AfroNP, BIOFAQUIM, and NuBBEDB. (<bold>C</bold>) Heatmap generated with Tanimoto scoring matrix of similar structures among compounds between PeruNPDB and control data sets.</p></caption><graphic xlink:href="41598_2023_34729_Fig6_HTML" id="MO6"/></fig></p>
    </sec>
    <sec id="Sec13">
      <title>Drug-likeness</title>
      <p id="Par14">Druglikeness assesses qualitatively the chance for a molecule to become an oral drug concerning bioavailability and is established from structural or physicochemical inspections of development compounds advanced enough to be considered oral drug candidates<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. To assess the “<italic>drug-like</italic>” profile of the compounds from the PeruNPDB two approaches were performed; firstly, the frequency distribution of the drug-likeness score was analyzed, and the results showed that besides the differences in the number of compounds compared in both datasets a similar distribution among the compounds is observed (Fig. <xref rid="Fig8" ref-type="fig">8</xref>A). In the second approach, the number of violations to Lipinski’s Ro5 was analyzed and the results showed that compounds with at least one violation represent the 85.82 and 76.35% of the FDA and PeruNPDB datasets, respectively (Fig. <xref rid="Fig8" ref-type="fig">8</xref>B). Also, the visual representation of the chemical space as PCAs (Fig. <xref rid="Fig8" ref-type="fig">8</xref>C) and t-SNE (Fig. <xref rid="Fig8" ref-type="fig">8</xref>D) indicates that some of the NPs are distributed in the same space as the already approved drugs. Whereas the explained variance percentage of PC1, PC2, and PC3 was 52.38, 37.64, and 5.54, respectively. The findings imply that because the compounds in PeruNPDB have chemical structures like those of approved medications, they can be used in virtual screening to find possible lead compounds or points for further optimization.<fig id="Fig7"><label>Figure 7</label><caption><p>Consensus diversity plot comparing the global diversity of PeruNPDB with the reference data sets.</p></caption><graphic xlink:href="41598_2023_34729_Fig7_HTML" id="MO7"/></fig><fig id="Fig8"><label>Figure 8</label><caption><p>Druglikeness analysis of the PeruNPDB and the reference datasets. (<bold>A</bold>) The similar distribution between FDA compounds and PeruNPDB. (<bold>B</bold>) Lipinski’s five rules from the FDA and PeruNPDB data sets. (<bold>C</bold>) Visual 3D representation of the chemical space as PCAs from the FDA and PeruNPDB data sets. (<bold>D</bold>) Representation t-SNE of FDA and PeruNPDB data sets.</p></caption><graphic xlink:href="41598_2023_34729_Fig8_HTML" id="MO8"/></fig></p>
    </sec>
  </sec>
  <sec id="Sec14">
    <title>Discussion</title>
    <p id="Par15">Peru has exceptionally high biodiversity, with numerous endemic species of mammals, reptiles, amphibians, flowering plants, and ferns, which is why has been described as a “<italic>megadiverse</italic>” country<sup><xref ref-type="bibr" rid="CR64">64</xref>,<xref ref-type="bibr" rid="CR65">65</xref></sup>, but worldwide hotspot analysis for potential conflict between food security and biodiversity conservation points out Peru as a region that is especially at risk of biodiversity loss due to agricultural expansion<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. Thus, the conservancy of biodiversity can be considered important since historically NPs have played a key role in drug discovery, especially for illnesses such as cancer, cardiovascular and infectious diseases<sup><xref ref-type="bibr" rid="CR67">67</xref></sup>, while the growing interest in NPs and their application is evidenced by a growth of the number of published databases of NPs, and collections of structures from various organisms, geographical locations, targeted diseases, and traditional applications<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>. Currently, several NPs or NPs-derived molecules are employed in the treatment of distinct diseases, such as the antibiotic penicillin originally obtained from the fungi <italic>Penicillium</italic> spp.<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>; the analgesic aspirin, which is the most used drug in the world, derived from salicin extracted from the bark of the willow trees <italic>Salix alba</italic><sup><xref ref-type="bibr" rid="CR70">70</xref></sup>; and the immunosuppressant tacrolimus employed in the prevention of the rejection organ after transplants, obtained from bacteria <italic>Streptomyces tsukubaensis</italic><sup><xref ref-type="bibr" rid="CR71">71</xref></sup>, are some examples. Besides, NPs and their derivatives have been considered promising options to improve treatment efficiency in cancer patients and decrease adverse reactions<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>, whereas vinca alkaloids<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>, taxane diterpenoids<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>, camptothecin derivatives<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>, and epipodophyllotoxin<sup><xref ref-type="bibr" rid="CR76">76</xref></sup>, are NPs-derived anticancer compounds clinically used as chemotherapeutics; while an example of the importance of biodiversity conservation is exemplified by the tree <italic>Taxus brevifolia</italic>, from which the chemotherapeutic drug paclitaxel was originally extracted, that was put on the list of endangered species<sup><xref ref-type="bibr" rid="CR77">77</xref>,<xref ref-type="bibr" rid="CR78">78</xref></sup>. According to the data, there are fewer compounds identified in the PeruNPDB than in AfroDB, BIOFAQUIM, and NuBBEDB, but the chemical diversity is also higher. Of the 280 compounds characterized, 95% came from plant sources, and 5% came from animal sources. But in the BIOFACQUIM and NuBBE databases as well as plant sources, compounds derived from fungi, propolis, bacteria, and marine organisms are also described. This partially explains the difference in the TPSA results of the PeruNPDB, since it has been reported that natural products from the animal kingdom have the highest TPSA due to the number of hydrogen bond donors and acceptors<sup><xref ref-type="bibr" rid="CR79">79</xref></sup>. Furthermore, the Peruvian marine biodiversity hotspot located on the northern coast has been predicted to hold 501 species, 270 genera, and 193 families<sup><xref ref-type="bibr" rid="CR80">80</xref></sup>, as marine natural products have shown an interesting array of diverse and novel chemical structures with potent biological activities<sup><xref ref-type="bibr" rid="CR81">81</xref></sup>, which includes: Cephalosporin C an antibiotic derived from marine fungi <italic>Cephalosporium</italic><sup><xref ref-type="bibr" rid="CR82">82</xref></sup>, Eribulin an anticancer drug derived from halichondrin B from the natural Japanese marine sponge <italic>Halichondria okada</italic><sup><xref ref-type="bibr" rid="CR83">83</xref></sup> and the antiviral, isolated from sponge <italic>Tethya crypta</italic>, nucleoside Ara-A<sup><xref ref-type="bibr" rid="CR84">84</xref></sup>. Also, Peru is considered a diverse country that has a very broad microbial diversity richness, however, remains slightly studied and exploited<sup><xref ref-type="bibr" rid="CR85">85</xref>,<xref ref-type="bibr" rid="CR86">86</xref></sup>. Fungi, the eukaryotic microorganisms, produce a tremendous number of NPs with diverse chemical structures and biological activities<sup><xref ref-type="bibr" rid="CR87">87</xref></sup>, such as lovastatin, the first statin approved as a hypercholesterolemic medication by the FDA, most frequently produced by <italic>Aspergillus terreus</italic><sup><xref ref-type="bibr" rid="CR88">88</xref></sup>, and cyclosporine A, a potent immunosuppressant that was initially used to prevent organ rejection, isolated from the fungal species <italic>Tolypocladium inflatum</italic> gams<sup><xref ref-type="bibr" rid="CR89">89</xref></sup>. Besides that no current drug has been developed from propolis, it is considered a very rich and complex chemical composition, while about 300 different chemicals components isolated from it, and which composition fluctuates according to parameters such as plant source, seasons harvesting, geography, type of bee flora, climate changes, and honeybee species<sup><xref ref-type="bibr" rid="CR90">90</xref>,<xref ref-type="bibr" rid="CR91">91</xref></sup>; highlighting Artepillin C, extracted from Brazilian green propolis, that showed in vitro<sup><xref ref-type="bibr" rid="CR92">92</xref></sup> and in vivo<sup><xref ref-type="bibr" rid="CR93">93</xref></sup> anti-inflammatory potential. These emphasize the urgency to promote and enhance the study of Peruvian NPs quantitatively and qualitatively. Compounds from Peruvian medicinal plants have been evaluated for their antidiabetic<sup><xref ref-type="bibr" rid="CR94">94</xref></sup>, anticancer<sup><xref ref-type="bibr" rid="CR95">95</xref></sup>, antiviral<sup><xref ref-type="bibr" rid="CR96">96</xref></sup>, antibiotic<sup><xref ref-type="bibr" rid="CR97">97</xref></sup>, and antiparasitic activities<sup><xref ref-type="bibr" rid="CR98">98</xref></sup>; however, most of the studies in the literature were in vitro performed over plants extracts, and little information about the potential of single compounds on these activities is described, while these promising results can be explained by synergistic interaction or multi-factorial effects between compounds present in the plant extracts studied<sup><xref ref-type="bibr" rid="CR99">99</xref></sup>. While pharmacodynamic synergy involves multiple substances acting on various receptor targets to enhance the overall therapeutic effect, and pharmacokinetic synergy involves substances with little to no activity helping the main active principle to reach the target by improving bioavailability or by reducing metabolism and excretion, this type of assay can hide the true potential of single molecules activity between different constituents of plant extracts<sup><xref ref-type="bibr" rid="CR100">100</xref></sup>. Thus, the concerted effort of experimental NPs research with CADD is continuously increasing; and recently, NPs from the Peruvian native plants <italic>Smallanthus sonchilofolius</italic>, <italic>Lepidium meyenii</italic> (40 compounds)<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>, and <italic>Uncaria tomentosa</italic> (26 compounds)<sup><xref ref-type="bibr" rid="CR101">101</xref></sup> were in silico analyzed for their antiviral activity against SARS-CoV-2. Also, the in silico polypharmaceutical potential of 84 NPs from <italic>S. sonchifolius</italic>, <italic>L. meyenii</italic>, <italic>Croton lechleri</italic>, <italic>U. tomentosa</italic>, <italic>Minthostachys mollis</italic>, and <italic>Physalis peruvianus</italic> was analyzed against Alzheimer’s disease<sup><xref ref-type="bibr" rid="CR102">102</xref></sup>.</p>
  </sec>
  <sec id="Sec15">
    <title>Conclusion</title>
    <p id="Par16">Here we present the first version of PeruNPDB, a compound database of NPs from Peru that includes 280 compounds from plant and animal sources. PeruNPDB was constructed curated, and maintained by the Computational Biology and Chemistry Research Group from the Universidad Catolica de Santa Maria, and it is freely accessible through the website <ext-link ext-link-type="uri" xlink:href="https://perunpdb.com.pe/">https://perunpdb.com.pe/</ext-link>. The PeruNPDB was envisioned as a tool for virtual screening, identifying promising compounds, serving as a springboard for further biotechnological products, and providing suggestions for conservation policies. The chemoinformatic characterization and analysis of the coverage and diversity of PeruNPDB in chemical space suggest broad coverage, overlapping with regions in the drug-like chemical space. The database contains an identification code (ID), the chemical name, bibliographic reference (name of the journal, year of publication, and DOI number), kingdom, genus, and species of the natural product, SMILES notation, and classification of the natural product. In the future, we want to launch the PeruNPDB version 2 with new computed molecular descriptors, NP stereochemical data, and the possibility to download several structures at once. The web-based user interface will also be improved and kept, and new NPs from various taxonomic ranks that aren’t included in the current edition will be added. Additionally, as we increase the quantity of NPs, we anticipate comparing the PeruNPDB with larger, more varied free datasets that are available in the literature. The complete PeruNPDB dataset for research purposes is available upon request and may be directed to and will be fulfilled by the lead contact Miguel Angel Chavez Fumagalli (mchavezf@ucsm.edu.pe).</p>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <notes notes-type="author-contribution">
    <title>Author contributions</title>
    <p>Conceptualization: J.L.M.F. and M.A.C-F.; data curation: H.L.B-C., L.G.R., and M.A.C-F.; formal analysis: J.L.M.F. and M.A.C-F.; funding acquisition: G.D.D-C. and M.A.C-F.; investigation H.L.B-C., L.G.R., M.A.C-P., E.G.C-R., A.E.C-L.; methodology: J.L.M.F. and M.A.C-F.; writing—review and editing: H.L.B-C., L.G.R., G.D.D-C., J.L.M.F., and M.A.C-F. All authors have read and agreed to the published version of the manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This research was funded by Universidad Catolica de Santa Maria (grants 27499-R-2020, 27574-R-2020, 7309-CU-2020, and 28048-R-2021) and by the Research Management Office from the Universidad Catolica de Santa Maria.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Data availibility</title>
    <p>The datasets generated and/or analyzed during the current study are available in the PeruNPDB repository, <ext-link ext-link-type="uri" xlink:href="https://perunpdb.com.pe/">https://perunpdb.com.pe/</ext-link>.</p>
  </notes>
  <notes notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par17">The authors declare no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hanley</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Perrings</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The economic value of biodiversity</article-title>
        <source>Annu. Rev. Resour. Econ.</source>
        <year>2019</year>
        <volume>11</volume>
        <fpage>355</fpage>
        <lpage>375</lpage>
        <pub-id pub-id-type="doi">10.1146/annurev-resource-100518-093946</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mora</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tittensor</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Adl</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Simpson</surname>
            <given-names>AG</given-names>
          </name>
          <name>
            <surname>Worm</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>How many species are there on earth and in the ocean?</article-title>
        <source>PLoS Biol.</source>
        <year>2011</year>
        <volume>9</volume>
        <fpage>e1001127</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pbio.1001127</pub-id>
        <?supplied-pmid 21886479?>
        <pub-id pub-id-type="pmid">21886479</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sweetlove</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Number of species on earth tagged at 8.7 million</article-title>
        <source>Nature</source>
        <year>2011</year>
        <volume>23</volume>
        <fpage>1</fpage>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Myers</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Mittermeier</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Mittermeier</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Da Fonseca</surname>
            <given-names>GA</given-names>
          </name>
          <name>
            <surname>Kent</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Biodiversity hotspots for conservation priorities</article-title>
        <source>Nature</source>
        <year>2000</year>
        <volume>403</volume>
        <fpage>853</fpage>
        <lpage>858</lpage>
        <pub-id pub-id-type="doi">10.1038/35002501</pub-id>
        <?supplied-pmid 10706275?>
        <pub-id pub-id-type="pmid">10706275</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <mixed-citation publication-type="other">Mittermeier, R. A., Turner, W. R., Larsen, F. W., Brooks, T. M. &amp; Gascon, C. Global biodiversity conservation: The critical role of hotspots. In <italic>Biodiversity Hotspots</italic>, 3–22 (Springer, 2011).</mixed-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fajardo</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lessmann</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bonaccorso</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Devenish</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Munoz</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Combined use of systematic conservation planning, species distribution modelling, and connectivity analysis reveals severe conservation gaps in a megadiverse country (peru)</article-title>
        <source>PLoS ONE</source>
        <year>2014</year>
        <volume>9</volume>
        <fpage>e114367</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0114367</pub-id>
        <?supplied-pmid 25479411?>
        <pub-id pub-id-type="pmid">25479411</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shanee</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Protected area coverage of threatened vertebrates and ecoregions in Peru: Comparison of communal, private and state reserves</article-title>
        <source>J. Environ. Manag.</source>
        <year>2017</year>
        <volume>202</volume>
        <fpage>12</fpage>
        <lpage>20</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jenvman.2017.07.023</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Institute</surname>
            <given-names>WR</given-names>
          </name>
        </person-group>
        <source>Ecosystems and Human Well-being: Biodiversity Synthesis</source>
        <year>2005</year>
        <publisher-name>World Resources Institute</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Newman</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Cragg</surname>
            <given-names>GM</given-names>
          </name>
        </person-group>
        <article-title>Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019</article-title>
        <source>J. Nat. Prod.</source>
        <year>2020</year>
        <volume>83</volume>
        <fpage>770</fpage>
        <lpage>803</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.jnatprod.9b01285</pub-id>
        <?supplied-pmid 32162523?>
        <pub-id pub-id-type="pmid">32162523</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Rai</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bhattarai</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Feitosa</surname>
            <given-names>CM</given-names>
          </name>
        </person-group>
        <source>Ethnopharmacology of Wild Plants</source>
        <year>2021</year>
        <publisher-name>CRC Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tresca</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Marcus</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Politi</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Evaluating herbal medicine preparation from a traditional perspective: Insights from an ethnopharmaceutical survey in the Peruvian Amazon</article-title>
        <source>Anthropol. Med.</source>
        <year>2020</year>
        <volume>27</volume>
        <fpage>268</fpage>
        <lpage>284</lpage>
        <pub-id pub-id-type="doi">10.1080/13648470.2019.1669939</pub-id>
        <?supplied-pmid 31958994?>
        <pub-id pub-id-type="pmid">31958994</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bussmann</surname>
            <given-names>RW</given-names>
          </name>
          <name>
            <surname>Sharon</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Plantas medicinales de los andes y la amazonía-la flora mágica y medicinal del norte del perú</article-title>
        <source>Ethnobotany Res. Appl.</source>
        <year>2016</year>
        <volume>15</volume>
        <fpage>1</fpage>
        <lpage>293</lpage>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <mixed-citation publication-type="other">de Salud Convenio Hipólito Unanue, O. A. Plantas medicinales de la subregión andina (2014).</mixed-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Achan</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Quinine, an old anti-malarial drug in a modern world: Role in the treatment of malaria</article-title>
        <source>Malar. J.</source>
        <year>2011</year>
        <volume>10</volume>
        <fpage>1</fpage>
        <lpage>12</lpage>
        <pub-id pub-id-type="doi">10.1186/1475-2875-10-144</pub-id>
        <pub-id pub-id-type="pmid">21214892</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Calatayud</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>González</surname>
            <given-names>Á</given-names>
          </name>
        </person-group>
        <article-title>History of the development and evolution of local anesthesia since the coca leaf</article-title>
        <source>J. Am. Soc. Anesthesiol.</source>
        <year>2003</year>
        <volume>98</volume>
        <fpage>1503</fpage>
        <lpage>1508</lpage>
        <pub-id pub-id-type="doi">10.1097/00000542-200306000-00031</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schottenhammer</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>“Peruvian balsam”: An example of transoceanic transfer of medicinal knowledge</article-title>
        <source>J. Ethnobiol. Ethnomed.</source>
        <year>2020</year>
        <volume>16</volume>
        <fpage>1</fpage>
        <lpage>20</lpage>
        <pub-id pub-id-type="doi">10.1186/s13002-020-00407-y</pub-id>
        <pub-id pub-id-type="pmid">31924218</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lock</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Perez</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Villar</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Flores</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Rojas</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Bioactive compounds from plants used in Peruvian traditional medicine</article-title>
        <source>Nat. Prod. Commun.</source>
        <year>2016</year>
        <volume>11</volume>
        <fpage>315</fpage>
        <lpage>37</lpage>
        <?supplied-pmid 27169179?>
        <pub-id pub-id-type="pmid">27169179</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gonzales</surname>
            <given-names>GF</given-names>
          </name>
          <name>
            <surname>Valerio</surname>
            <given-names>LG</given-names>
          </name>
        </person-group>
        <article-title>Medicinal plants from Peru: A review of plants as potential agents against cancer</article-title>
        <source>Anti-Cancer Agents Med. Chem. (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)</source>
        <year>2006</year>
        <volume>6</volume>
        <fpage>429</fpage>
        <lpage>444</lpage>
        <pub-id pub-id-type="doi">10.2174/187152006778226486</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bussmann</surname>
            <given-names>RW</given-names>
          </name>
        </person-group>
        <article-title>The globalization of traditional medicine in northern perú: from shamanism to molecules</article-title>
        <source>Evid.-based Complement. Altern. Med.</source>
        <year>2013</year>
        <volume>2013</volume>
        <fpage>291903</fpage>
        <pub-id pub-id-type="doi">10.1155/2013/291903</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sabe</surname>
            <given-names>VT</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review</article-title>
        <source>Eur. J. Med. Chem.</source>
        <year>2021</year>
        <volume>224</volume>
        <fpage>113705</fpage>
        <pub-id pub-id-type="doi">10.1016/j.ejmech.2021.113705</pub-id>
        <?supplied-pmid 34303871?>
        <pub-id pub-id-type="pmid">34303871</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gimeno</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The light and dark sides of virtual screening: What is there to know?</article-title>
        <source>Int. J. Mol. Sci.</source>
        <year>2019</year>
        <volume>20</volume>
        <fpage>1375</fpage>
        <pub-id pub-id-type="doi">10.3390/ijms20061375</pub-id>
        <?supplied-pmid 30893780?>
        <pub-id pub-id-type="pmid">30893780</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Masic</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Ferhatovica</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Review of most important biomedical databases for searching of biomedical scientific literature</article-title>
        <source>DSJUOG</source>
        <year>2012</year>
        <volume>6</volume>
        <fpage>343</fpage>
        <lpage>61</lpage>
        <pub-id pub-id-type="doi">10.5005/jp-journals-10009-1258</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sorokina</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Merseburger</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Rajan</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Yirik</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Steinbeck</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Coconut online: Collection of open natural products database</article-title>
        <source>J. Cheminform.</source>
        <year>2021</year>
        <volume>13</volume>
        <fpage>1</fpage>
        <lpage>13</lpage>
        <pub-id pub-id-type="doi">10.1186/s13321-020-00478-9</pub-id>
        <pub-id pub-id-type="pmid">33407901</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rutz</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The lotus initiative for open knowledge management in natural products research</article-title>
        <source>Elife</source>
        <year>2022</year>
        <volume>11</volume>
        <fpage>e70780</fpage>
        <pub-id pub-id-type="doi">10.7554/eLife.70780</pub-id>
        <?supplied-pmid 35616633?>
        <pub-id pub-id-type="pmid">35616633</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>CY-C</given-names>
          </name>
        </person-group>
        <article-title>TCM database@ Taiwan: The world’s largest traditional Chinese medicine database for drug screening in silico</article-title>
        <source>PLoS ONE</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>e15939</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0015939</pub-id>
        <?supplied-pmid 21253603?>
        <pub-id pub-id-type="pmid">21253603</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mohanraj</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>IMPPAT: A curated database of Indian medicinal plants, phytochemistry and therapeutics</article-title>
        <source>Sci. Rep.</source>
        <year>2018</year>
        <volume>8</volume>
        <fpage>1</fpage>
        <lpage>17</lpage>
        <pub-id pub-id-type="doi">10.1038/s41598-018-22631-z</pub-id>
        <pub-id pub-id-type="pmid">29311619</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ntie-Kang</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>AfroDb: A select highly potent and diverse natural product library from African medicinal plants</article-title>
        <source>PLoS ONE</source>
        <year>2013</year>
        <volume>8</volume>
        <fpage>e78085</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0078085</pub-id>
        <?supplied-pmid 24205103?>
        <pub-id pub-id-type="pmid">24205103</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pilon</surname>
            <given-names>AC</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>NuBBE<sub>DB</sub>: An updated database to uncover chemical and biological information from Brazilian biodiversity</article-title>
        <source>Sci. Rep.</source>
        <year>2017</year>
        <volume>7</volume>
        <fpage>1</fpage>
        <lpage>12</lpage>
        <pub-id pub-id-type="doi">10.1038/s41598-017-07451-x</pub-id>
        <pub-id pub-id-type="pmid">28127051</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Scotti</surname>
            <given-names>MT</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>SistematX, an online web-based cheminformatics tool for data management of secondary metabolites</article-title>
        <source>Molecules</source>
        <year>2018</year>
        <volume>23</volume>
        <fpage>103</fpage>
        <pub-id pub-id-type="doi">10.3390/molecules23010103</pub-id>
        <?supplied-pmid 29301376?>
        <pub-id pub-id-type="pmid">29301376</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pilón-Jiménez</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Saldívar-González</surname>
            <given-names>FI</given-names>
          </name>
          <name>
            <surname>Díaz-Eufracio</surname>
            <given-names>BI</given-names>
          </name>
          <name>
            <surname>Medina-Franco</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>BIOFACQUIM: A Mexican compound database of natural products</article-title>
        <source>Biomolecules</source>
        <year>2019</year>
        <volume>9</volume>
        <fpage>31</fpage>
        <pub-id pub-id-type="doi">10.3390/biom9010031</pub-id>
        <?supplied-pmid 30658522?>
        <pub-id pub-id-type="pmid">30658522</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gómez-García</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Medina-Franco</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>Progress and impact of Latin American natural product databases</article-title>
        <source>Biomolecules</source>
        <year>2022</year>
        <volume>12</volume>
        <fpage>1202</fpage>
        <pub-id pub-id-type="doi">10.3390/biom12091202</pub-id>
        <?supplied-pmid 36139041?>
        <pub-id pub-id-type="pmid">36139041</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Acevedo</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Scotti</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Scotti</surname>
            <given-names>MT</given-names>
          </name>
        </person-group>
        <article-title>In silico studies designed to select sesquiterpene lactones with potential antichagasic activity from an in-house asteraceae database</article-title>
        <source>ChemMedChem</source>
        <year>2018</year>
        <volume>13</volume>
        <fpage>634</fpage>
        <lpage>645</lpage>
        <pub-id pub-id-type="doi">10.1002/cmdc.201700743</pub-id>
        <?supplied-pmid 29323468?>
        <pub-id pub-id-type="pmid">29323468</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>do Carmo Santos</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>da Paixão</surname>
            <given-names>VG</given-names>
          </name>
          <name>
            <surname>da Rocha Pita</surname>
            <given-names>SS</given-names>
          </name>
        </person-group>
        <article-title>New <italic>Trypanosoma cruzi</italic> trypanothione reductase inhibitors identification using the virtual screening in database of nucleus bioassay, biosynthesis and ecophysiology (NuBBE)</article-title>
        <source>Anti-Infect. Agents</source>
        <year>2019</year>
        <volume>17</volume>
        <fpage>138</fpage>
        <lpage>149</lpage>
        <pub-id pub-id-type="doi">10.2174/2211352516666180928130031</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Antunes</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Rabelo</surname>
            <given-names>VW-H</given-names>
          </name>
          <name>
            <surname>Romeiro</surname>
            <given-names>NC</given-names>
          </name>
        </person-group>
        <article-title>Natural products from Brazilian biodiversity identified as potential inhibitors of PknA and PknB of <italic>M. tuberculosis</italic> using molecular modeling tools</article-title>
        <source>Comput. Biol. Med.</source>
        <year>2021</year>
        <volume>136</volume>
        <fpage>104694</fpage>
        <pub-id pub-id-type="doi">10.1016/j.compbiomed.2021.104694</pub-id>
        <?supplied-pmid 34365277?>
        <pub-id pub-id-type="pmid">34365277</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Herrera-Acevedo</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Selection of antileishmanial sesquiterpene lactones from SistematX database using a combined ligand-/structure-based virtual screening approach</article-title>
        <source>Mol. Divers.</source>
        <year>2021</year>
        <volume>25</volume>
        <fpage>2411</fpage>
        <lpage>2427</lpage>
        <pub-id pub-id-type="doi">10.1007/s11030-020-10139-6</pub-id>
        <?supplied-pmid 32909084?>
        <pub-id pub-id-type="pmid">32909084</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <mixed-citation publication-type="other">Ccahuana, H. L. B. <italic>et al.</italic> In silico-based screening for natural products structural analogs as new drugs candidate against leishmaniasis. <italic>bioRxiv</italic> (2022).</mixed-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Menezes</surname>
            <given-names>RPBD</given-names>
          </name>
          <name>
            <surname>Viana</surname>
            <given-names>JDO</given-names>
          </name>
          <name>
            <surname>Muratov</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Scotti</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Scotti</surname>
            <given-names>MT</given-names>
          </name>
        </person-group>
        <article-title>Computer-assisted discovery of alkaloids with schistosomicidal activity</article-title>
        <source>Curr. Issues Mol. Biol.</source>
        <year>2022</year>
        <volume>44</volume>
        <fpage>383</fpage>
        <lpage>408</lpage>
        <pub-id pub-id-type="doi">10.3390/cimb44010028</pub-id>
        <?supplied-pmid 35723407?>
        <pub-id pub-id-type="pmid">35723407</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rodrigues</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Ligand and structure-based virtual screening of lamiaceae diterpenes with potential activity against a novel coronavirus (2019-NCOV)</article-title>
        <source>Curr. Top. Med. Chem.</source>
        <year>2020</year>
        <volume>20</volume>
        <fpage>2126</fpage>
        <lpage>2145</lpage>
        <pub-id pub-id-type="doi">10.2174/1568026620666200716114546</pub-id>
        <?supplied-pmid 32674732?>
        <pub-id pub-id-type="pmid">32674732</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Goyzueta-Mamani</surname>
            <given-names>LD</given-names>
          </name>
          <name>
            <surname>Barazorda-Ccahuana</surname>
            <given-names>HL</given-names>
          </name>
          <name>
            <surname>Mena-Ulecia</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Chávez-Fumagalli</surname>
            <given-names>MA</given-names>
          </name>
        </person-group>
        <article-title>Antiviral activity of metabolites from Peruvian plants against SARS-CoV-2: An in silico approach</article-title>
        <source>Molecules</source>
        <year>2021</year>
        <pub-id pub-id-type="doi">10.3390/molecules26133882</pub-id>
        <?supplied-pmid 34202092?>
        <pub-id pub-id-type="pmid">34202092</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>White</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Pubmed 2.0</article-title>
        <source>Med. Ref. Serv. Q.</source>
        <year>2020</year>
        <volume>39</volume>
        <fpage>382</fpage>
        <lpage>387</lpage>
        <pub-id pub-id-type="doi">10.1080/02763869.2020.1826228</pub-id>
        <?supplied-pmid 33085945?>
        <pub-id pub-id-type="pmid">33085945</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rogers</surname>
            <given-names>FB</given-names>
          </name>
        </person-group>
        <article-title>Medical subject headings</article-title>
        <source>Bull. Med. Lib. Assoc.</source>
        <year>1963</year>
        <volume>51</volume>
        <fpage>114</fpage>
        <lpage>116</lpage>
        <?supplied-pmid 13982385?>
        <pub-id pub-id-type="pmid">13982385</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Van Eck</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Waltman</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Citation-based clustering of publications using CitNetExplorer and VOSviewer</article-title>
        <source>Scientometrics</source>
        <year>2017</year>
        <volume>111</volume>
        <fpage>1053</fpage>
        <lpage>1070</lpage>
        <pub-id pub-id-type="doi">10.1007/s11192-017-2300-7</pub-id>
        <?supplied-pmid 28490825?>
        <pub-id pub-id-type="pmid">28490825</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Waltman</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Van Eck</surname>
            <given-names>NJ</given-names>
          </name>
        </person-group>
        <article-title>A new methodology for constructing a publication-level classification system of science</article-title>
        <source>J. Am. Soc. Inf. Sci. Technol.</source>
        <year>2012</year>
        <volume>63</volume>
        <fpage>2378</fpage>
        <lpage>2392</lpage>
        <pub-id pub-id-type="doi">10.1002/asi.22748</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Weininger</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Smiles, a chemical language and information system. 1. Introduction to methodology and encoding rules</article-title>
        <source>J. Chem. Inf. Comput. Sci.</source>
        <year>1988</year>
        <volume>28</volume>
        <fpage>31</fpage>
        <lpage>36</lpage>
        <pub-id pub-id-type="doi">10.1021/ci00057a005</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Pubchem 2019 update: Improved access to chemical data</article-title>
        <source>Nucl. Acids Res.</source>
        <year>2019</year>
        <volume>47</volume>
        <fpage>D1102</fpage>
        <lpage>D1109</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1033</pub-id>
        <?supplied-pmid 30371825?>
        <pub-id pub-id-type="pmid">30371825</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wishart</surname>
            <given-names>DS</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Drugbank 5.0: A major update to the DrugBank database for 2018</article-title>
        <source>Nucl. Acids Res.</source>
        <year>2018</year>
        <volume>46</volume>
        <fpage>D1074</fpage>
        <lpage>D1082</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1037</pub-id>
        <?supplied-pmid 29126136?>
        <pub-id pub-id-type="pmid">29126136</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mendez</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ChEMBL: Towards direct deposition of bioassay data</article-title>
        <source>Nucl. Acids Res.</source>
        <year>2019</year>
        <volume>47</volume>
        <fpage>D930</fpage>
        <lpage>D940</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1075</pub-id>
        <?supplied-pmid 30398643?>
        <pub-id pub-id-type="pmid">30398643</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Evans</surname>
            <given-names>DA</given-names>
          </name>
        </person-group>
        <article-title>History of the Harvard ChemDraw project</article-title>
        <source>Angew. Chem. Int. Ed.</source>
        <year>2014</year>
        <volume>53</volume>
        <fpage>11140</fpage>
        <lpage>11145</lpage>
        <pub-id pub-id-type="doi">10.1002/anie.201405820</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sander</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Freyss</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>von Korff</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Rufener</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>DataWarrior: An open-source program for chemistry aware data visualization and analysis</article-title>
        <source>J. Chem. Inf. Model.</source>
        <year>2015</year>
        <volume>55</volume>
        <fpage>460</fpage>
        <lpage>473</lpage>
        <pub-id pub-id-type="doi">10.1021/ci500588j</pub-id>
        <?supplied-pmid 25558886?>
        <pub-id pub-id-type="pmid">25558886</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fillbrunn</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>KNIME for reproducible cross-domain analysis of life science data</article-title>
        <source>J. Biotechnol.</source>
        <year>2017</year>
        <volume>261</volume>
        <fpage>149</fpage>
        <lpage>156</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jbiotec.2017.07.028</pub-id>
        <?supplied-pmid 28757290?>
        <pub-id pub-id-type="pmid">28757290</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>HW</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>NPClassifier: A deep neural network-based structural classification tool for natural products</article-title>
        <source>J. Nat. Prod.</source>
        <year>2021</year>
        <volume>84</volume>
        <fpage>2795</fpage>
        <lpage>2807</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.jnatprod.1c00399</pub-id>
        <?supplied-pmid 34662515?>
        <pub-id pub-id-type="pmid">34662515</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Djoumbou Feunang</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ClassyFire: Automated chemical classification with a comprehensive, computable taxonomy</article-title>
        <source>J. Cheminform.</source>
        <year>2016</year>
        <volume>8</volume>
        <fpage>1</fpage>
        <lpage>20</lpage>
        <pub-id pub-id-type="doi">10.1186/s13321-016-0174-y</pub-id>
        <pub-id pub-id-type="pmid">26807156</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bro</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Smilde</surname>
            <given-names>AK</given-names>
          </name>
        </person-group>
        <article-title>Principal component analysis</article-title>
        <source>Anal. Methods</source>
        <year>2014</year>
        <volume>6</volume>
        <fpage>2812</fpage>
        <lpage>2831</lpage>
        <pub-id pub-id-type="doi">10.1039/C3AY41907J</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Probst</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Reymond</surname>
            <given-names>J-L</given-names>
          </name>
        </person-group>
        <article-title>Visualization of very large high-dimensional data sets as minimum spanning trees</article-title>
        <source>J. Cheminform.</source>
        <year>2020</year>
        <volume>12</volume>
        <fpage>1</fpage>
        <lpage>13</lpage>
        <pub-id pub-id-type="doi">10.1186/s13321-020-0416-x</pub-id>
        <pub-id pub-id-type="pmid">33430988</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Charisi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>L-C</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Girke</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>ChemmineR: A compound mining framework for R</article-title>
        <source>Bioinformatics</source>
        <year>2008</year>
        <volume>24</volume>
        <fpage>1733</fpage>
        <lpage>1734</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btn307</pub-id>
        <?supplied-pmid 18596077?>
        <pub-id pub-id-type="pmid">18596077</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <mixed-citation publication-type="other">Team, R. C. <italic>R: A Language and Environment for Statistical Computing</italic>. <ext-link ext-link-type="uri" xlink:href="http://www.R-project.org/">http://www.R-project.org/</ext-link> (R Foundation for Statistical Computing, 2013).</mixed-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Irwin</surname>
            <given-names>JJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ZINC20—a free ultralarge-scale chemical database for ligand discovery</article-title>
        <source>J. Chem. Inf. Model.</source>
        <year>2020</year>
        <volume>60</volume>
        <fpage>6065</fpage>
        <lpage>6073</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.jcim.0c00675</pub-id>
        <?supplied-pmid 33118813?>
        <pub-id pub-id-type="pmid">33118813</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>González-Medina</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Prieto-Martínez</surname>
            <given-names>FD</given-names>
          </name>
          <name>
            <surname>Owen</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Medina-Franco</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>Consensus diversity plots: A global diversity analysis of chemical libraries</article-title>
        <source>J. Cheminform.</source>
        <year>2016</year>
        <volume>8</volume>
        <fpage>1</fpage>
        <lpage>11</lpage>
        <pub-id pub-id-type="doi">10.1186/s13321-016-0176-9</pub-id>
        <pub-id pub-id-type="pmid">26807156</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Medina-Franco</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Martínez-Mayorga</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Bender</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Scior</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Scaffold diversity analysis of compound data sets using an entropy-based measure</article-title>
        <source>QSAR Combinatorial Sci.</source>
        <year>2009</year>
        <volume>28</volume>
        <fpage>1551</fpage>
        <lpage>1560</lpage>
        <pub-id pub-id-type="doi">10.1002/qsar.200960069</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kuwahara</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Analysis of the effects of related fingerprints on molecular similarity using an eigenvalue entropy approach</article-title>
        <source>J. Cheminform.</source>
        <year>2021</year>
        <volume>13</volume>
        <fpage>1</fpage>
        <lpage>12</lpage>
        <pub-id pub-id-type="doi">10.1186/s13321-021-00506-2</pub-id>
        <pub-id pub-id-type="pmid">33407901</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>López-López</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Naveja</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Medina-Franco</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>DataWarrior: An evaluation of the open-source drug discovery tool</article-title>
        <source>Expert Opin. Drug Discov.</source>
        <year>2019</year>
        <volume>14</volume>
        <fpage>335</fpage>
        <lpage>341</lpage>
        <pub-id pub-id-type="doi">10.1080/17460441.2019.1581170</pub-id>
        <?supplied-pmid 30806519?>
        <pub-id pub-id-type="pmid">30806519</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kralj</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jukič</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bren</surname>
            <given-names>U</given-names>
          </name>
        </person-group>
        <article-title>Comparative analyses of medicinal chemistry and cheminformatics filters with accessible implementation in Konstanz information miner (KNIME)</article-title>
        <source>Int. J. Mol. Sci.</source>
        <year>2022</year>
        <volume>23</volume>
        <fpage>5727</fpage>
        <pub-id pub-id-type="doi">10.3390/ijms23105727</pub-id>
        <?supplied-pmid 35628532?>
        <pub-id pub-id-type="pmid">35628532</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Daina</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Michielin</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Zoete</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>SwissABME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules</article-title>
        <source>Sci. Rep.</source>
        <year>2017</year>
        <volume>7</volume>
        <fpage>1</fpage>
        <lpage>13</lpage>
        <pub-id pub-id-type="doi">10.1038/srep42717</pub-id>
        <pub-id pub-id-type="pmid">28127051</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rodríguez</surname>
            <given-names>LO</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>KR</given-names>
          </name>
        </person-group>
        <article-title>Biological diversity of Peru: Determining priority areas for conservation</article-title>
        <source>AMBIO J. Hum. Environ.</source>
        <year>2000</year>
        <volume>29</volume>
        <fpage>329</fpage>
        <lpage>337</lpage>
        <pub-id pub-id-type="doi">10.1579/0044-7447-29.6.329</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>McNeely</surname>
            <given-names>JA</given-names>
          </name>
          <etal/>
        </person-group>
        <source>Conserving the World’s Biological Diversity</source>
        <year>1990</year>
        <publisher-name>International Union for Conservation of Nature and Natural Resources</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Molotoks</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kuhnert</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dawson</surname>
            <given-names>TP</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Global hotspots of conflict risk between food security and biodiversity conservation</article-title>
        <source>Land</source>
        <year>2017</year>
        <volume>6</volume>
        <fpage>67</fpage>
        <pub-id pub-id-type="doi">10.3390/land6040067</pub-id>
      </element-citation>
    </ref>
    <ref id="CR67">
      <label>67.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Atanasov</surname>
            <given-names>AG</given-names>
          </name>
          <name>
            <surname>Zotchev</surname>
            <given-names>SB</given-names>
          </name>
          <name>
            <surname>Dirsch</surname>
            <given-names>VM</given-names>
          </name>
          <name>
            <surname>Supuran</surname>
            <given-names>CT</given-names>
          </name>
        </person-group>
        <article-title>Natural products in drug discovery: Advances and opportunities</article-title>
        <source>Nat. Rev. Drug Discov.</source>
        <year>2021</year>
        <volume>20</volume>
        <fpage>200</fpage>
        <lpage>216</lpage>
        <pub-id pub-id-type="doi">10.1038/s41573-020-00114-z</pub-id>
        <?supplied-pmid 33510482?>
        <pub-id pub-id-type="pmid">33510482</pub-id>
      </element-citation>
    </ref>
    <ref id="CR68">
      <label>68.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sorokina</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Steinbeck</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Review on natural products databases: Where to find data in 2020</article-title>
        <source>J. Cheminform.</source>
        <year>2020</year>
        <volume>12</volume>
        <fpage>1</fpage>
        <lpage>51</lpage>
        <pub-id pub-id-type="doi">10.1186/s13321-020-00424-9</pub-id>
        <pub-id pub-id-type="pmid">33430988</pub-id>
      </element-citation>
    </ref>
    <ref id="CR69">
      <label>69.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gaynes</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>The discovery of penicillin-new insights after more than 75 years of clinical use</article-title>
        <source>Emerg. Infect. Dis.</source>
        <year>2017</year>
        <volume>23</volume>
        <fpage>849</fpage>
        <pub-id pub-id-type="doi">10.3201/eid2305.161556</pub-id>
      </element-citation>
    </ref>
    <ref id="CR70">
      <label>70.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Montinari</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Minelli</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>De Caterina</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>The first 3500 years of aspirin history from its roots—A concise summary</article-title>
        <source>Vasc. Pharmacol.</source>
        <year>2019</year>
        <volume>113</volume>
        <fpage>1</fpage>
        <lpage>8</lpage>
        <pub-id pub-id-type="doi">10.1016/j.vph.2018.10.008</pub-id>
      </element-citation>
    </ref>
    <ref id="CR71">
      <label>71.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tanaka</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Nakahara</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hatanaka</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Inamura</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kuroda</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Discovery and development of a novel immunosuppressant, tacrolimus hydrate</article-title>
        <source>Yakugaku Zasshi J. Pharm. Soc. Jpn.</source>
        <year>1997</year>
        <volume>117</volume>
        <fpage>542</fpage>
        <lpage>554</lpage>
        <pub-id pub-id-type="doi">10.1248/yakushi1947.117.8_542</pub-id>
      </element-citation>
    </ref>
    <ref id="CR72">
      <label>72.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Choudhari</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Mandave</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Deshpande</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ranjekar</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Prakash</surname>
            <given-names>O</given-names>
          </name>
        </person-group>
        <article-title>Phytochemicals in cancer treatment: From preclinical studies to clinical practice</article-title>
        <source>Front. Pharmacol.</source>
        <year>2020</year>
        <volume>10</volume>
        <fpage>1614</fpage>
        <pub-id pub-id-type="doi">10.3389/fphar.2019.01614</pub-id>
        <?supplied-pmid 32116665?>
        <pub-id pub-id-type="pmid">32116665</pub-id>
      </element-citation>
    </ref>
    <ref id="CR73">
      <label>73.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Martino</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead</article-title>
        <source>Bioorganic Med. Chem. Lett.</source>
        <year>2018</year>
        <volume>28</volume>
        <fpage>2816</fpage>
        <lpage>2826</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bmcl.2018.06.044</pub-id>
      </element-citation>
    </ref>
    <ref id="CR74">
      <label>74.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oudard</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Cabazitaxel versus docetaxel as first-line therapy for patients with metastatic castration-resistant prostate cancer: A randomized phase iii trial-firstana</article-title>
        <source>J. Clin. Oncol.</source>
        <year>2017</year>
        <volume>35</volume>
        <fpage>3189</fpage>
        <lpage>3197</lpage>
        <pub-id pub-id-type="doi">10.1200/JCO.2016.72.1068</pub-id>
        <?supplied-pmid 28753384?>
        <pub-id pub-id-type="pmid">28753384</pub-id>
      </element-citation>
    </ref>
    <ref id="CR75">
      <label>75.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hertzberg</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Caranfa</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Hecht</surname>
            <given-names>SM</given-names>
          </name>
        </person-group>
        <article-title>On the mechanism of topoisomerase i inhibition by camptothecin: Evidence for binding to an enzyme-DNA complex</article-title>
        <source>Biochemistry</source>
        <year>1989</year>
        <volume>28</volume>
        <fpage>4629</fpage>
        <lpage>4638</lpage>
        <pub-id pub-id-type="doi">10.1021/bi00437a018</pub-id>
        <?supplied-pmid 2548584?>
        <pub-id pub-id-type="pmid">2548584</pub-id>
      </element-citation>
    </ref>
    <ref id="CR76">
      <label>76.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cao</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Cip-36, a novel topoisomerase II-targeting agent, induces the apoptosis of multidrug-resistant cancer cells in vitro</article-title>
        <source>Int. J. Mol. Med.</source>
        <year>2015</year>
        <volume>35</volume>
        <fpage>771</fpage>
        <lpage>776</lpage>
        <pub-id pub-id-type="doi">10.3892/ijmm.2015.2068</pub-id>
        <?supplied-pmid 25592869?>
        <pub-id pub-id-type="pmid">25592869</pub-id>
      </element-citation>
    </ref>
    <ref id="CR77">
      <label>77.</label>
      <mixed-citation publication-type="other">Mayor, S. Tree that provides paclitaxel is put on list of endangered species (2011).</mixed-citation>
    </ref>
    <ref id="CR78">
      <label>78.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Murage</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Batalha</surname>
            <given-names>HR</given-names>
          </name>
          <name>
            <surname>Lino</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sterniczuk</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>From drug discovery to coronaviruses: Why restoring natural habitats is good for human health</article-title>
        <source>BMJ</source>
        <year>2021</year>
        <volume>375</volume>
        <fpage>n2329</fpage>
        <pub-id pub-id-type="doi">10.1136/bmj.n2329</pub-id>
        <?supplied-pmid 34610952?>
        <pub-id pub-id-type="pmid">34610952</pub-id>
      </element-citation>
    </ref>
    <ref id="CR79">
      <label>79.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pilkington</surname>
            <given-names>LI</given-names>
          </name>
        </person-group>
        <article-title>A chemometric analysis of deep-sea natural products</article-title>
        <source>Molecules</source>
        <year>2019</year>
        <volume>24</volume>
        <fpage>3942</fpage>
        <pub-id pub-id-type="doi">10.3390/molecules24213942</pub-id>
        <?supplied-pmid 31683674?>
        <pub-id pub-id-type="pmid">31683674</pub-id>
      </element-citation>
    </ref>
    <ref id="CR80">
      <label>80.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Miloslavich</surname>
            <given-names>P</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Marine biodiversity in the Atlantic and Pacific coasts of South America: Knowledge and gaps</article-title>
        <source>PLoS ONE</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>e14631</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0014631</pub-id>
        <?supplied-pmid 21304960?>
        <pub-id pub-id-type="pmid">21304960</pub-id>
      </element-citation>
    </ref>
    <ref id="CR81">
      <label>81.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jeong</surname>
            <given-names>G-J</given-names>
          </name>
          <name>
            <surname>Khan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tabassum</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Khan</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>Y-M</given-names>
          </name>
        </person-group>
        <article-title>Marine-bioinspired nanoparticles as potential drugs for multiple biological roles</article-title>
        <source>Mar. Drugs</source>
        <year>2022</year>
        <volume>20</volume>
        <fpage>527</fpage>
        <pub-id pub-id-type="doi">10.3390/md20080527</pub-id>
        <?supplied-pmid 36005529?>
        <pub-id pub-id-type="pmid">36005529</pub-id>
      </element-citation>
    </ref>
    <ref id="CR82">
      <label>82.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Silber</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kramer</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Labes</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tasdemir</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>From discovery to production: Biotechnology of marine fungi for the production of new antibiotics</article-title>
        <source>Mar. Drugs</source>
        <year>2016</year>
        <volume>14</volume>
        <fpage>137</fpage>
        <pub-id pub-id-type="doi">10.3390/md14070137</pub-id>
        <?supplied-pmid 27455283?>
        <pub-id pub-id-type="pmid">27455283</pub-id>
      </element-citation>
    </ref>
    <ref id="CR83">
      <label>83.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Swami</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Shah</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Goel</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Eribulin in cancer treatment</article-title>
        <source>Mar. Drugs</source>
        <year>2015</year>
        <volume>13</volume>
        <fpage>5016</fpage>
        <lpage>5058</lpage>
        <pub-id pub-id-type="doi">10.3390/md13085016</pub-id>
        <?supplied-pmid 26262627?>
        <pub-id pub-id-type="pmid">26262627</pub-id>
      </element-citation>
    </ref>
    <ref id="CR84">
      <label>84.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sagar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kaur</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Minneman</surname>
            <given-names>KP</given-names>
          </name>
        </person-group>
        <article-title>Antiviral lead compounds from marine sponges</article-title>
        <source>Mar. drugs</source>
        <year>2010</year>
        <volume>8</volume>
        <fpage>2619</fpage>
        <lpage>2638</lpage>
        <pub-id pub-id-type="doi">10.3390/md8102619</pub-id>
        <?supplied-pmid 21116410?>
        <pub-id pub-id-type="pmid">21116410</pub-id>
      </element-citation>
    </ref>
    <ref id="CR85">
      <label>85.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vega</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Production of alkaline cellulase by fungi isolated from an undisturbed rain forest of peru</article-title>
        <source>Biotechnol. Res.Int.</source>
        <year>2012</year>
        <volume>2012</volume>
        <fpage>934325</fpage>
        <pub-id pub-id-type="doi">10.1155/2012/934325</pub-id>
        <?supplied-pmid 23213539?>
        <pub-id pub-id-type="pmid">23213539</pub-id>
      </element-citation>
    </ref>
    <ref id="CR86">
      <label>86.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Plata</surname>
            <given-names>ER</given-names>
          </name>
          <name>
            <surname>Lücking</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>High diversity of graphidaceae (lichenized ascomycota: Ostropales) in Amazonian Perú</article-title>
        <source>Fungal Divers.</source>
        <year>2013</year>
        <volume>58</volume>
        <fpage>13</fpage>
        <lpage>32</lpage>
        <pub-id pub-id-type="doi">10.1007/s13225-012-0172-y</pub-id>
      </element-citation>
    </ref>
    <ref id="CR87">
      <label>87.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Du</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Compartmentalized biosynthesis of fungal natural products</article-title>
        <source>Curr. Opin. Biotechnol.</source>
        <year>2021</year>
        <volume>69</volume>
        <fpage>128</fpage>
        <lpage>135</lpage>
        <pub-id pub-id-type="doi">10.1016/j.copbio.2020.12.006</pub-id>
        <?supplied-pmid 33450704?>
        <pub-id pub-id-type="pmid">33450704</pub-id>
      </element-citation>
    </ref>
    <ref id="CR88">
      <label>88.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Al-Saman</surname>
            <given-names>MA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Optimization of lovastatin production by <italic>Aspergillus terreus</italic> ATCC 10020 using solid-state fermentation and its pharmacological applications</article-title>
        <source>Biocatal. Agric. Biotechnol.</source>
        <year>2021</year>
        <volume>31</volume>
        <fpage>101906</fpage>
        <pub-id pub-id-type="doi">10.1016/j.bcab.2021.101906</pub-id>
      </element-citation>
    </ref>
    <ref id="CR89">
      <label>89.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Colombo</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ammirati</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Cyclosporine in transplantation—A history of converging timelines</article-title>
        <source>J. Biol. Regul. Homeost. Agents</source>
        <year>2011</year>
        <volume>25</volume>
        <fpage>493</fpage>
        <lpage>504</lpage>
        <?supplied-pmid 22217983?>
        <pub-id pub-id-type="pmid">22217983</pub-id>
      </element-citation>
    </ref>
    <ref id="CR90">
      <label>90.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hossain</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Propolis: An update on its chemistry and pharmacological applications</article-title>
        <source>Chin. Med.</source>
        <year>2022</year>
        <volume>17</volume>
        <fpage>1</fpage>
        <lpage>60</lpage>
        <pub-id pub-id-type="doi">10.1186/s13020-022-00651-2</pub-id>
        <pub-id pub-id-type="pmid">34980192</pub-id>
      </element-citation>
    </ref>
    <ref id="CR91">
      <label>91.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Silva-Carvalho</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Baltazar</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Almeida-Aguiar</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Propolis: a complex natural product with a plethora of biological activities that can be explored for drug development</article-title>
        <source>Evidence-Based Complementary Altern. Medicine</source>
        <year>2015</year>
        <volume>2015</volume>
        <fpage>206439</fpage>
        <pub-id pub-id-type="doi">10.1155/2015/206439</pub-id>
      </element-citation>
    </ref>
    <ref id="CR92">
      <label>92.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Paulino</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Anti-inflammatory effects of a bioavailable compound, artepillin c, in Brazilian propolis</article-title>
        <source>Eur. J. Pharmacol.</source>
        <year>2008</year>
        <volume>587</volume>
        <fpage>296</fpage>
        <lpage>301</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ejphar.2008.02.067</pub-id>
        <?supplied-pmid 18474366?>
        <pub-id pub-id-type="pmid">18474366</pub-id>
      </element-citation>
    </ref>
    <ref id="CR93">
      <label>93.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moura</surname>
            <given-names>SALD</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Aqueous extract of brazilian green propolis: primary components, evaluation of inflammation and wound healing by using subcutaneous implanted sponges</article-title>
        <source>Evidence-Based Complementary Altern. Medicine</source>
        <year>2011</year>
        <volume>2011</volume>
        <fpage>748283</fpage>
        <pub-id pub-id-type="doi">10.1093/ecam/nep112</pub-id>
      </element-citation>
    </ref>
    <ref id="CR94">
      <label>94.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Guillen Quispe</surname>
            <given-names>YN</given-names>
          </name>
          <name>
            <surname>Hwang</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zuo</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>SS</given-names>
          </name>
        </person-group>
        <article-title>Screening in vitro targets related to diabetes in herbal extracts from Peru: Identification of active compounds in <italic>Hypericum laricifolium</italic> Juss. by offline high-performance liquid chromatography</article-title>
        <source>Int. J. Mol. Sci.</source>
        <year>2017</year>
        <volume>18</volume>
        <fpage>2512</fpage>
        <pub-id pub-id-type="doi">10.3390/ijms18122512</pub-id>
        <pub-id pub-id-type="pmid">29186785</pub-id>
      </element-citation>
    </ref>
    <ref id="CR95">
      <label>95.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bautista-Flores</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mayor</surname>
            <given-names>PNA</given-names>
          </name>
          <name>
            <surname>Arellano</surname>
            <given-names>AAL</given-names>
          </name>
        </person-group>
        <article-title>Cytotoxic effect of hydroalcoholic extract of annona muricata against a human cell line of gastric adenocarcinoma</article-title>
        <source>Vitae</source>
        <year>2022</year>
        <volume>29</volume>
        <fpage>1</fpage>
        <lpage>9</lpage>
        <pub-id pub-id-type="doi">10.17533/udea.vitae.v29n1a348194</pub-id>
      </element-citation>
    </ref>
    <ref id="CR96">
      <label>96.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Roumy</surname>
            <given-names>V</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Viral hepatitis in the Peruvian Amazon: Ethnomedical context and phytomedical resource</article-title>
        <source>J. Ethnopharmacol.</source>
        <year>2020</year>
        <volume>255</volume>
        <fpage>112735</fpage>
        <pub-id pub-id-type="doi">10.1016/j.jep.2020.112735</pub-id>
        <?supplied-pmid 32147478?>
        <pub-id pub-id-type="pmid">32147478</pub-id>
      </element-citation>
    </ref>
    <ref id="CR97">
      <label>97.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Roumy</surname>
            <given-names>V</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>In vitro antimicrobial activity of traditional plant used in mestizo shamanism from the Peruvian amazon in case of infectious diseases</article-title>
        <source>Pharmacogn. Mag.</source>
        <year>2015</year>
        <volume>11</volume>
        <fpage>S625</fpage>
        <pub-id pub-id-type="doi">10.4103/0973-1296.172975</pub-id>
        <?supplied-pmid 27013805?>
        <pub-id pub-id-type="pmid">27013805</pub-id>
      </element-citation>
    </ref>
    <ref id="CR98">
      <label>98.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Céline</surname>
            <given-names>V</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Medicinal plants from the Yanesha (Peru): Evaluation of the leishmanicidal and antimalarial activity of selected extracts</article-title>
        <source>J. Ethnopharmacol.</source>
        <year>2009</year>
        <volume>123</volume>
        <fpage>413</fpage>
        <lpage>422</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jep.2009.03.041</pub-id>
        <pub-id pub-id-type="pmid">19514108</pub-id>
      </element-citation>
    </ref>
    <ref id="CR99">
      <label>99.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Williamson</surname>
            <given-names>EM</given-names>
          </name>
        </person-group>
        <article-title>Synergy and other interactions in phytomedicines</article-title>
        <source>Phytomedicine</source>
        <year>2001</year>
        <volume>8</volume>
        <fpage>401</fpage>
        <lpage>409</lpage>
        <pub-id pub-id-type="doi">10.1078/0944-7113-00060</pub-id>
        <?supplied-pmid 11695885?>
        <pub-id pub-id-type="pmid">11695885</pub-id>
      </element-citation>
    </ref>
    <ref id="CR100">
      <label>100.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rasoanaivo</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Wright</surname>
            <given-names>CW</given-names>
          </name>
          <name>
            <surname>Willcox</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Gilbert</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Whole plant extracts versus single compounds for the treatment of malaria: Synergy and positive interactions</article-title>
        <source>Malar. J.</source>
        <year>2011</year>
        <volume>10</volume>
        <fpage>1</fpage>
        <lpage>12</lpage>
        <pub-id pub-id-type="doi">10.1186/1475-2875-10-S1-S4</pub-id>
        <pub-id pub-id-type="pmid">21214892</pub-id>
      </element-citation>
    </ref>
    <ref id="CR101">
      <label>101.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yepes-Pérez</surname>
            <given-names>AF</given-names>
          </name>
          <name>
            <surname>Herrera-Calderon</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Quintero-Saumeth</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title><italic>Uncaria tomentosa</italic> (cat’s claw): A promising herbal medicine against SARS-CoV-2/ACE-2 junction and SARS-CoV-2 spike protein based on molecular modeling</article-title>
        <source>J. Biomol. Struct. Dyn.</source>
        <year>2022</year>
        <volume>40</volume>
        <fpage>2227</fpage>
        <lpage>2243</lpage>
        <pub-id pub-id-type="doi">10.1080/07391102.2020.1837676</pub-id>
        <?supplied-pmid 33118480?>
        <pub-id pub-id-type="pmid">33118480</pub-id>
      </element-citation>
    </ref>
    <ref id="CR102">
      <label>102.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Goyzueta-Mamani</surname>
            <given-names>LD</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>In silico analysis of metabolites from Peruvian native plants as potential therapeutics against Alzheimer’s disease</article-title>
        <source>Molecules</source>
        <year>2022</year>
        <volume>27</volume>
        <fpage>918</fpage>
        <pub-id pub-id-type="doi">10.3390/molecules27030918</pub-id>
        <?supplied-pmid 35164183?>
        <pub-id pub-id-type="pmid">35164183</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
